Edison, NJ—White matter lesions (WMLs) of the brain that partially obstruct blood flow are associated with problems like stroke and cognitive decline and could be linked to future stroke risk. A new study, published in Stroke, suggests that a full-spectrum palm-derived mixed tocotrienol complex (Tocomin SupraBio, from Carotech, based here) may help.
A group of Malaysian researchers worked with 121 individuals that had cardiovascular risk factors and WMLs. For two years, volunteers either took a placebo or the branded mixed tocotrienols (200 mg twice daily). MRIs looked for WMLs at baseline, at one year and at two years, and bloodwork was taken. By the end of the second year, WMLs increased in the placebo group but remained unchanged in those taking the tocotrienols.
“Considerable evidence exists that palm tocotrienol complex protects stroke-induced injuries in vitro and in animal studies,” said WH Leong, vice president of Carotech. “This study clearly demonstrates a neuroprotective effect of Tocomin SupraBio supplementation in humans.
Published in WholeFoods Magazine, June 2014